SLXNSilexion Therapeutics Corp · Nasdaq · $2.73M mkt cap
Assessed Oct 7, 2026 · Float drift
Is the float you're seeing correct?
10.71M
Estimated float

DEF 14A count of 14,473,292 shares at 9/30, less officer and director holdings and less the Sponsor's 13.5% block (1,954,241 beneficially owned minus 37 warrant shares).

Understated 25%
8.59M
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Your screener is showing a float that no longer exists. Trade off 10.71M shares.

Dilution risk8/10HIGH
CONFIDENCE: MEDIUM

The float your screener shows is understated 25%: 8.59M reported, 10.71M actual. An active $9.2M ATM, 1 convertible note and 4 reverse splits can add another 75% of the float.

  • Rapid share count growth. Outstanding shares went from 1,349,019 (2026-08-06) to 5,560,256 (2026-08-13) to 14,473,292 (2026-09-30): about 10.7x in 8 weeks.

  • At-the-money warrant overhang unlocking. 7,288,274 warrants (3.22M Series F, 3.22M Series G, 629K Series E at $0.2603, and 225K PA at $0.3254) sit at or near the $0.2628 price.

  • Oversized ATM vs market cap. The HCW ATM has $9.2M remaining against a $3.8M market cap (2.4x).

From today's float to the ceiling

shares
10.71M
Estimated float
tradeable today
+629.2K can sell now
11.34M
Effective supply
float plus what sells on notice
+11.19M if floors are cut and warrants exercise
22.53M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
10.71M
Can sell now
Registered resale shares, issuable on notice
Already effective; the holder can sell without a further filing.
+629.2K
Warrants in the money
None of the outstanding warrants are exercisable at this price.
+0
Effective supply
11.34M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+8.05M
Options and RSUs
Employee equity; vests and settles over time.
+4.9K
Other, per engine ceiling
Included in the engine's fully-diluted count but not itemised in the filings we parsed.
+3.13M
Fully diluted
22.53M

ATM program active with $9.2M of registered capacity remaining. Sales are paced by the agent against daily volume; the headline figure is not the near-term supply.

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
—
Market cap
$2.73M
Shares outstanding
14.47M
Reported float
8.59M
Avg volume
1.76M
Reverse splits
4 · latest 1:15 to 1:25 · Oct 19, 2026
Going concern
Yes · 0.8 quarters runway
Quarterly burn
$2.90M

Market data as of Oct 26, 2026

Key dates

  • Oct 28, 2026 · Deadline to file resale S-3 for 6,433,856 F/G warrant shares
  • Nov 30, 2026 · Nasdaq bid-price compliance deadline (approx.); another raise or inducement is likely around the split
  • Feb 15, 2027 · Original Sponsor note maturity; litigation outcome could produce settlement shares